DOI QR코드

DOI QR Code

Pulmonary Arterial Thrombosis in a Patient With an Atrial Septal Defect and Eisenmenger Syndrome

  • Lee, Ching-Wei (Division of Cardiology, Department of Internal Medicine, Taipei Veterans General Hospital and National Yang-Ming University) ;
  • Huang, Shao-Sung (Division of Cardiology, Department of Internal Medicine, Taipei Veterans General Hospital and National Yang-Ming University) ;
  • Huang, Po-Hsun (Division of Cardiology, Department of Internal Medicine, Taipei Veterans General Hospital and National Yang-Ming University)
  • 발행 : 2012.11.30

초록

Pulmonary hypertension is characterized by elevated pulmonary arterial pressure and secondary right ventricular failure. A thromboembolic occlusion of the proximal or distal pulmonary vasculature results in chronic thromboembolic pulmonary hypertension. We report an uncommon case that presented to our hospital with symptoms of dyspnea on exertion over 2 years. The patient had been treated for profound pulmonary thrombosis and right ventricular failure with adequate anticoagulation and sildenafil. Our echocardiography disclosed a large atrial septal defect with severe pulmonary hypertension and right ventricular failure. A diagnosis of Eisenmenger syndrome with pulmonary artery thrombosis was made. Although Eisenmenger syndrome with pulmonary thrombosis is well described in western societies, a huge pulmonary thrombosis is seldom reported in eastern countries. Profound pulmonary thrombosis may obfuscate the actual diagnosis of pulmonary artery hypertension with underlying congenital heart disease. A physical examination and echocardiography are essential in patients with pulmonary hypertension.

키워드

참고문헌

  1. Hassell KL. Altered hemostasis in pulmonary hypertension. Blood Coagul Fibrinolysis 1998;9:107-17. https://doi.org/10.1097/00001721-199803000-00001
  2. Broberg CS, Ujita M, Prasad S, et al. Pulmonary arterial thrombosis in Eeisenmenger syndrome is associated with biventricular dysfunction and decreased pulmonary flow velocity. J Am Coll Cardiol 2007;50:634-42. https://doi.org/10.1016/j.jacc.2007.04.056
  3. Silversides CK, Granton JT, Konen E, Hart MA, Webb GD, Therrien J. Pulmonary thrombosis in adults with Eisenmenger syndrome. J Am Coll Cardiol 2003;42:1982-7. https://doi.org/10.1016/j.jacc.2003.07.022
  4. Jensen AS, Iversen K, Vejlstrup NG, Sondergaard L. Images in cardiovascular medicine: pulmonary artery thrombosis and hemoptysis in Eisenmenger syndrome. Circulation 2007;115:e632-4. https://doi.org/10.1161/CIRCULATIONAHA.107.695312
  5. Broberg C, Ujita M, Babu-Narayan S, et al. Massive pulmonary artery thrombosis with haemoptysis in adults with Eisenmenger's syndrome: a clinical dilemma. Heart 2004;90:e63. https://doi.org/10.1136/hrt.2004.039198
  6. Piazza G, Goldhaber SZ. Chronic thromboembolic pulmonary hypertension. N Engl J Med 2011;364:351-60. https://doi.org/10.1056/NEJMra0910203
  7. Moser KM, Fedullo PF, Finkbeiner WE, Golden J. Do patients with primary pulmonary hypertension develop extensive central thrombi? Circulation 1995;91:741-5. https://doi.org/10.1161/01.CIR.91.3.741
  8. Niwa K, Perloff JK, Kaplan S, Child JS, Miner PD. Eisenmenger syndrome in adults: ventricular septal defect, truncus arteriosus, univentricular heart. J Am Coll Cardiol 1999;34:223-32. https://doi.org/10.1016/S0735-1097(99)00153-9
  9. Niwa K, Perloff JK, Bhuta SM, et al. Structural abnormalities of great arterial walls in congenital heart disease: light and electron microscopic analyses. Circulation 2001;103:393-400. https://doi.org/10.1161/01.CIR.103.3.393
  10. Lopes AA, Caramurú LH, Maeda NY. Endothelial dysfunction associated with chronic intravascular coagulation in secondary pulmonary hypertension. Clin Appl Thromb Hemost 2002;8:353-8. https://doi.org/10.1177/107602960200800407
  11. Fuster V, Steele PM, Edwards WD, Gersh BJ, McGoon MD, Frye RL. Primary pulmonary hypertension: natural history and the importance of thrombosis. Circulation 1984;70:580-7. https://doi.org/10.1161/01.CIR.70.4.580
  12. Rich S, Kaufmann E, Levy PS. The effect of high doses of calcium channel blockers on survival in primary pulmonary hypertension. N Engl J Med 1992;327:76-81. https://doi.org/10.1056/NEJM199207093270203
  13. Beghetti M, Gallè N. Eisenmenger syndrome a clinical perspective in a new therapeutic era of pulmonary arterial hypertension. J Am Coll Cardiol 2009;53:733-40. https://doi.org/10.1016/j.jacc.2008.11.025

피인용 문헌

  1. Changes of Pulmonary Function and Serum Markers Expression in Asthmatic Children with Pulmonary Hypertension vol.10, pp.7, 2012, https://doi.org/10.12677/acm.2020.107176